[Featured Stock] Solgo Bio Escapes Delisting Risk, Hits Upper Limit for Two Consecutive Days
[Asia Economy Reporter Ji Yeon-jin] On the 24th, Solgo Bio surged to the daily price limit for the second consecutive day following the decision to maintain its listing.
Solgo Bio is trading at 993 won, up 29.97% from the previous day, shortly after the opening of the KOSDAQ market. The company had its trading suspended since February last year due to reasons for a delisting review, including operating losses for five consecutive business years.
Hot Picks Today
The Quoted 800,000 Won, the Bill Was 5 Million....
- Tragedy in Luxury Apartment: Woman in Her 20s Found Dead, Suspect Identified
- "You Can Only Have This in Korea": Which National Museum Cafe Menu Is Captivatin...
- They Say They'd Rather Go to Japan Than Travel Domestically... But a 'Surprising...
- "Never Hike Alone as a Woman" "Even Two Are at Risk"... Growing Fear of Crime on...
The KOSDAQ Market Headquarters of the Korea Exchange announced on the 22nd that the reasons for delisting had been resolved and decided to maintain Solgo Bio's listing. Since trading resumed, the stock has hit the upper price limit for two consecutive days.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
